Use your brains! AFFY is finished! and will be suspended soon.
If you bought at $2 or $3 then why do you care if you sell for tax loss at 15 cents or 5 cents? It doesn't make barely any difference. The important part is that you sell before Dec. 31st. Then you can buy back after 30 days. Even if this goes to 1 cent, I advise you to sell to me so that you can get tax loss and I can be happy. That will be win-win. Please sell AFFY shares to me for 1 penny. Thank you so much.
There are many unanswered questions, why rush the settlement before the truth comes out?
To whom did Affymax executives entrust the investigation of the SAEs?
Were they unaware of Takeda's reputation?
Did they subscribe to the same reporting practices? (see below Dr Helen Ge)
What was in the Fresenius evaluation Affymax refuses to make public?
Who had access to the Fresenius evaluation? Did they sell their shares?
"Takeda and Eli Lilly ordered to pay $9 billion over Actos drug" LATimes
Case 1:10-cv-11043-FDS Document 17 Filed 04/05/12
Dr. Ge had direct knowledge of the Actos bladder cancer risk and encountered resistance from her superiors when she tried to report bladder cancer as related to Actos. Dr. Ge claims her supervisors directed her to change her “related” assessment to unrelated. According to her recollection of reviewing Takeda’s adverse event database for Actos, there were more than 100 bladder cancers reported to the company, but only 72 reported to the FDA, which she alleges is a serious discrepancy.
It doesn't take a genius to figure out an attorney may settle for anything in order to guarantee approval of their fees. Is it true the insider trading reforms may be a substantial benefit to shareholders and therefore justify awarding these fees. Given the company has no source of income and very limited funds, not to mention the BOD's intention to dissolve the company, it won't prove true. The added costs associated with the reforms will probably hasten the demise of the company which the BOD would welcome. I believe the settlement negotiations lacked shareholder representation. It appears to me as if the counsel for the plaintiff bargained for a substantial fee, in return the defendants got absolution and immunity from future prosecution for yet unknown facts. Sadly I know the judges do not have all the relevant facts in either the Derivative Action or the Shareholder Class Action. They rely on the integrity of the attorneys presenting the case. The fees are based on reported extensive research by the law firms involved. So many hours yet lacking perhaps a few critical items that might change the judge's ruling. One thing I am sure of, to say not a single shareholder objected is a misrepresentation of the truth. I have spoken to Jeff Kaban of Cooley for the defendants, Marshall Dees of Holzer & Holzer for plaintiff Michael Markland, Joan Rabutaso of Robbins Arroyo for plaintiff Christopher Scott, and Leigh Smollar for the plaintiff in the shareholder class action. I did get a helpful piece of advice from the only attorney who no longer had a financial interest in the outcome. With that I asked if they could expand the class to include purchasers after Feb. 22, 2013 and include insiders selling after the Fresenius evaluation was completed.
I remarked to the FDA that it would be terrible if files went missing in this matter as they did in the Actos case.
It would be even worse if the judge allows language in the settlement referring to "Unknown"
check his other 2 stocks: XTLS ( suspended by SEC as a Fraud), MYRX, going to be suspended soon.
Because his Xstelos Holdings, Inc. holding 3.6 million AFFY worthless shares, he's trying every effort to pump it and wish other naive people to buy his worthless shares so that he could Escape from AFFY.
Sooner, you'll see AFFY to be suspended by SEC as SEC is watching CouchScam closely, then you'll lose everything, like those who did in XTLS.
I would like to buy some more shares at 10 cents or below. I think this is going to zero but I still think it is a good long-shot chance. If Couch Man can use NOLs then this will be a player. O has killed many people but that is not an issue any more. Please do the smart thing and sell for tax losses. You can always buy back later in January. Thank you.
So, go check CouchScam's history and his other 2 stocks: XTLS ( suspended by SEC, as a Fraud) and MYRX ( near suspension). Now, you'll know the fate of AFFY.
Google and read this: yahoo + A Special Meeting of stockholders was held on December 23, 2013
It says he reduced the number of shareholders to 300 by doing a reverse 1 for 2000 split followed by a 2000 for 1 split.
Put that together with the wording in his tender offer for Affy.
"purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, or changing their intention with respect to any and all matters referred to in Item 4."
And as I've said before why, if the NOLs are worth millions, put a 10 cent limit on the offering? .
So anyone who has communication with Couchman might ask him if he intends to cash out the small investors before they share in any benefits of those NOLs.
My wife and I own shares in affy and I have spent a good deal of time trying to get answers from Affymax, Fresenius, Takeda, lawyers in the derivative and shareholder class actions, the California court, FDA, and the SEC.
Why are you obsessed with couchman's maneuvers. Do you think he gives a ratsaz about shareholders.
Why aren't you concerned about these lawsuits that are limiting your rights for no other reason than several law firms making an easy windfall off the deaths of few patients without proving a thing. If you find out affy executives engaged in the same tactics as Takeda did with Actos the day after the class action settlement is granted will you have any recourse?
Please note that the lead plaintiff in the shareholder class action isn't a part of the reduced class.
Please note those lawyers who took an oath of integrity failed to notify the judge of objections to these settlements. I really can't see how the judge wouldn't object to the settlement so as to protect shareholders rights from a settlement which lacked shareholder representation. This is all very disturbing. Throw in the obnoxious shorts trying to profit from the deaths and its almost unbearable but I do it.
is trying hard to get his huge losses covered, so he released Fake pr in order to Dump his worthless shares.
Be very careful! You buy, he's pocketing your money. Go check his other 2 Frauds: XTLS and MYRX.
LOSS: $480 Million! It's finished.
soon, as CouchScam is on SEC watchlist for stock fraud.
You'll lose everything like he did in XTLS.
I think its funny that Couchman actually trapped anyone still short on thanksgiving into paying divy. If he is half as good at getting some revenue in play affy may pay off big.
Remind you of anyone.
So what happens when you're short and there's a dividend. And that preferred share.
Do you think its nervous energy or panic, all these posts of late.
After he dumps his worthless shares with the news, he might change his minds NOT to distribute the 5 cent dividends and put the rest shareholders' money in his own pocket.
From his history, you know what he is!
Couchman who is currently at the helm of the company is also currently President and CEO of Myrexis, Inc. (OTCMKTS:MYRX).
If you are wondering what is MYRX’s current state you might not be very pleased by the answer. The company is currently listed as OTC Pink No Information, the last financial report being a 10-K for the period ended June 31, 2013 in which MYRX recorded 1.13 million in cash, $0 in revenues and $11.62 million in net loss, 99% of which were made up from general and administrative expenses.
CouchScam has no money to acquire asset, go check his other 2 frauds: XTLS and MYRX, LOL! Being a Scammer, his XTLS was Suspended by SEC in Sep. AFFY is the next!
$0.20s close? Is that the same as thirteen cents?
the next to be suspended by SEC soon, as CouchScam is on the SEC watchlist for frauds.
Never believe what a #$%$ says!
definitely a scam to create liquidity and get out. NOL's are worthless unless the company acquires an asset that earns taxable income. Changes in beneficial ownership wipe out NOL's